What are the WHO treatment guidelines for pharyngeal gonococcal infections?

Updated: Sep 07, 2018
  • Author: Brian Wong, MD; Chief Editor: Pranatharthi Haran Chandrasekar, MBBS, MD  more...
  • Print
Answer

In adults and adolescents with gonococcal oropharyngeal infections, the WHO suggests dual therapy over single therapy.

Dual therapy options are as follows:

  • Ceftriaxone 250 mg IM as a single dose PLUS azithromycin 1 g PO as a single dose or
  • Cefixime 400 mg PO as a single dose PLUS azithromycin 1 g PO as a single dose

Single-drug therapy (based on recent local resistance data confirming susceptibility to the antimicrobial) consists of ceftriaxone 250 mg IM as single dose.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!